RUTOVEN

This brand name is authorized in Poland

Active ingredients

The drug RUTOVEN contains one active pharmaceutical ingredient (API):

1 Troxerutin
UNII 7Y4N11PXO8 - TROXERUTIN

The pharmacodynamic effects of oxerutins have been demonstrated in different in vitro and in vivo studies. At the cellular level the capability of oxerutins to protect the vascular wall from the oxidative attack of activated blood cells and its affinity to the endothelium of capillaries and venoles could be shown.

Read about Troxerutin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C05CA04 Troxerutin C Cardiovascular system → C05 Vasoprotectives → C05C Capillary stabilizing agents → C05CA Bioflavonoids
Discover more medicines within C05CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: PL Rejestru Produktรณw Leczniczych Identifier(s): 100059131

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.